Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Kuribayashi T, Kinoshita R, Ninomiya K, Makimoto G, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Maeda Y, Kiura K, Toyooka S, Sakaguchi M, Ohashi K.
Kuribayashi T, et al. Among authors: hotta k.
Sci Rep. 2025 Jan 20;15(1):2577. doi: 10.1038/s41598-025-87232-z.
Sci Rep. 2025.
PMID: 39833332
Free PMC article.